Le Lézard
Classified in: Health, Science and technology

Global Marine Biotechnology Market Expected to Grow with a CAGR of 8% During the Forecast Period, 2020-2024 - ResearchAndMarkets.com


The "Global Marine Biotechnology Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Global Marine Biotechnology Market 2020-2024

The analyst has been monitoring the global marine biotechnology market and it is poised to grow by USD 2.5 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period.

This report on the global marine biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in demand for biofuel. In addition, increasing application of seaweeds is anticipated to boost the growth of the global marine biotechnology market as well.

Key Trends for global marine biotechnology market growth

This study identifies increasing application of seaweeds as the prime reasons driving the global marine biotechnology market growth during the next few years.

Key Topics Covered:

Executive Summary

Market Landscape

Market Sizing

Five Forces Analysis

Market Segmentation by Application

Customer landscape

Geographic Landscape

Drivers, Challenges, and Trends

Vendor Landscape

Vendor Analysis

Appendix

For more information about this report visit https://www.researchandmarkets.com/r/4va2oa


These press releases may also interest you

at 06:05
Athersys, Inc. ("Athersys") announced today that its partner in Japan, HEALIOS K.K. ("Healios"), exercised in full its warrant to purchase shares of Athersys common stock. Healios purchased 4,000,000 shares at a price of $1.76 per share in...

at 06:05
Revive Therapeutics Ltd. ("Revive" or the "Company") , a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, is pleased to provide a corporate update on its plans for the Company's...

at 06:05
Achieves key secondary endpoints demonstrating rapid and statistically significant improvements in depressive symptoms on MADRS versus active comparator at Weeks 1, 2, and overall (key secondary endpoints, p=0.02, 0.035, and 0.031) Demonstrated...

at 06:01
Around 20 surgeons and 20 nurses from leading European hospitals, across urology, gynaecology and general surgery participated in Dexter validation end of February and early March 2020 Surgical teams successfully performed surgical procedures using...

at 06:00
AbbVie issued the following form today. IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR...

at 06:00
In the news release, Three Squared Adapts Residential Shipping Containers to Help End COVID-19 Hospital Housing Shortage, issued 29-Mar-2020 by Three Squared, Inc. over PR Newswire, we are advised by the company that the media contact's email address...



News published on 27 february 2020 at 09:55 and distributed by: